SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹74 Cr | ₹49 Cr | ₹20 Cr | ₹25 Cr | ₹33 Cr |
What is the latest Total Non-Current Liabilities ratio of SUDEEP PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹74 Cr |
| Mar2025 | ₹49 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹33 Cr |
How is Total Non-Current Liabilities of SUDEEP PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹74 Cr | 51.70 | |
| Mar2025 | ₹49 Cr | 140.41 | |
| Mar2024 | ₹20 Cr | -19.93 | |
| Mar2023 | ₹25 Cr | -23.98 | |
| Mar2022 | ₹33 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹11,930.7 Cr | -5% | -12% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -5% |
-12% |
|
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses